NFE2L2 and pancreatic neoplasm: Similar to recent reports in lung cancer cells (17–19), knockdown of NRF2 (NRF2-KD) by siRNA reduced the proliferation of AsPC-1 pancreatic cancer cells over the times tested (Fig. 1A).